Get started
Author

Ayumi Kaneda

Observed names: 亜弓 兼田, 兼田, 亜弓
Institution: Kyowa Kirin (Japan)
ORCID: 0009-0007-9788-682X
Observed ORCID: 0009-0007-9788-682X
OpenAlex ID: A5011268967
The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
2020 · Ayumi Kaneda, Toshihiro Seike, et al. · American Journal of Cancer Research · 136
Inhibition of macrophage activation and suppression of graft rejection by DTCM-glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone
2011 · Masatoshi Takeiri, Miyuki Tachibana, et al. · Inflammation Research · 33
Efficacy and exploratory biomarker analysis of entinostat plus exemestane in advanced or recurrent breast cancer: phase II randomized controlled trial
2022 · Hiroji Iwata, Rikiya Nakamura, et al. · Japanese Journal of Clinical Oncology · 16
PDF
Abstract 3086: Discovery of a first-in-class TEAD inhibitor which directly inhibits YAP/TAZ-TEAD protein-protein interaction and shows a potent anti-tumor effect in malignant pleural mesothelioma
2019 · Ayumi Kaneda, Toshihiro Seike, et al. · Cancer Research · 11
Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-glutarimide
2015 · Naoki Koide, Ayumi Kaneda, et al. · International Immunopharmacology · 10
A long-lasting PI3Kδ inhibitor zandelisib forms a water-shielded hydrogen bond with p110δ and demonstrates sustained inhibitory effects
2025 · Kana Kunieda, Chisae Nagiri, et al. · American Journal of Cancer Research · 5
PDF
Abstract 3086: Discovery of afirst-in-classTEAD inhibitor which directly inhibits YAP/TAZ-TEAD protein-protein interaction and shows a potent anti-tumor effect in malignant pleural mesothelioma
2019 · Ayumi Kaneda, Toshihiro Seike, et al. · Experimental and Molecular Therapeutics · 5
The novel and potent CD40 agonist KHK2840 augments the antitumor efficacy of anti‐ PD ‐1 antibody and paclitaxel
2024 · Chiaki Kobayashi, Minami Suzuki‐Imaizumi, et al. · Cancer Science · 3
PDF
Ингибирование Клеточной Инвазии И Индуцирование Аноикоза В Клетках Меланомы У Мышей При Помощи Противовоспалительного Препарата Dtcm Глутаримида
2012 · Ayumi Kaneda, Ш. Х. Ганцев, et al. · DOAJ (DOAJ: Directory of Open Access Journals) · 3
固形悪性腫瘍に対する新規 Yap1-tead シグナル阻害剤の創製
2022 · 兼田, 亜弓, Kabeya, Ayumi · Institutional Repositories DataBase (IRDB)
PDF
Abstract 2913: Entinostat (KHK2375), class I histone deacetylase inhibitor, regulates human Treg function by decreasing Foxp3 expression and effector Treg population
2020 · Hiromichi Kosaka, Yozo Nishimura, et al. · Cancer Research
P-61 9-methylstreptymidone由来新規PDK-1阻害物質DTCM-glutarimideによるin vivo炎症反応の抑制(ポスター発表の部)
2011 · あゆみ 伊藤, 雅敏 竹入, et al. · 天然有機化合物討論会講演要旨集
P-23 DTCM-glutarimideによるマウスメラノーマ細胞の浸潤抑制とanoikis誘導(ポスター発表の部)
2010 · 亜弓 兼田, 裕一 石川, et al. · 天然有機化合物討論会講演要旨集
P-75 新規転写因子AP-1活性阻害剤DTCM-glutarimideの作用機構と生物活性(ポスター発表の部)
2009 · 亜弓 兼田, みゆき 橘, et al. · 天然有機化合物討論会講演要旨集
Works count: 14
Citation count: 222
H-index: 5
I10-index: 5
Year
Topic
Type